Review: Anticonvulsants are better than placebo for reducing the frequency of migraine attacks

Chronicle, E.
January 2005
ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p21
Academic Journal
The article reports that anticonvulsants are better than placebo for reducing the frequency of migraine attacks. Studies were selected if they were randomized controlled trials that compared anticonvulsants given regularly during headache-free intervals in adults greater than 18 years of age with placebo, no intervention, other drug treatments or behavioral or physical therapies. Headache frequency, headache index measures and adverse events. The most common adverse events were nausea.


Related Articles

  • Review: intravenous metocloprarnide is better than placebo For reducing pain in acute migraine in the emergency department. Loder, Elizabeth W. // Evidence Based Medicine;Jun2005, Vol. 10 Issue 3, p83 

    The article presents information on a study published in the 2004 issue of the British Medical Journal, which analyzed if meloclopramide is more effective than a control intervention for reducing symptoms in patients with acute migraine. In studies comparing drug combinations, more patients...

  • Is osteopathic manipulation effective for headaches? Keays, Ashley C.; Neher, Jon O.; Safranek, Sarah // Journal of Family Practice;Mar2008, Vol. 57 Issue 3, p190 

    The article cites several studies which examine the efficacy of spinal manipulative therapy (SMT) for the treatment of headaches. The studies reveal that SMT has been more effective than placebo for the prophylactic treatment of cervicogenic headaches, as well as acute tension headaches....

  • Importance of Placebo Effect in Cough Clinical Trials. Eccles, Ron // Lung;Feb2010 Supplement 1, Vol. 188, p53 

    Cough is a unique symptom because, unlike sneeze and other symptoms, it can be under voluntary control and this complicates clinical trials on cough medicines. All over-the-counter cough medicines (OTC) are very effective treatments because of their placebo effect. The placebo effect is enhanced...

  • Use of Electroacupuncture for Treatment of Chronic Sciatic Pain. Hollisaz, Mohammad Taghi // Internet Journal of Pain, Symptom Control & Palliative Care;2007, Vol. 5 Issue 1, p1 

    Introduction: Chronic sciatic pain is one of the most common complaints of patients referring to orthopaedic, neurosurgery, and physiatric clinics. In most cases, common treatment modalities may be employed. However, in many, the results are not be consistent. Electroacupuncture has been...

  • Augmented visual feedback of movement performance to enhance walking recovery after stroke: study protocol for a pilot randomised controlled trial. Thikey, Heather; Grealy, Madeleine; van Wijck, Frederike; Barber, Mark; Rowe, Philip // Trials;2012, Vol. 13 Issue 1, p163 

    Background: Increasing evidence suggests that use of augmented visual feedback could be a useful approach to stroke rehabilitation. In current clinical practice, visual feedback of movement performance is often limited to the use of mirrors or video. However, neither approach is optimal since...

  • Acacia's Series B Adds $24M for PONV Drug; NDA in 2014. Moran, Nuala // BioWorld Today;9/4/2013, Vol. 24 Issue 169, p1 

    The article reports on a Series B funding round completed by pharmaceutical company Acacia Ltd. According to the article, the 15 million British pounds raised will be used to file a new drug application in the middle of 2014 and to finalize Phase III development of APD421, the company's main...

  • Acupressure and vitamin B6 to relieve nausea and vomiting in pregnancy: a randomized study. Jamigorn, Mattawan; Phupong, Vorapong // Archives of Gynecology & Obstetrics;Oct2007, Vol. 276 Issue 3, p245 

    To compare the effectiveness of acupressure and vitamin B6 in the outpatient treatment of nausea and vomiting in early pregnancy. Pregnant volunteers with symptoms of mild to moderate nausea and vomiting between 6 and 12 weeks’ gestation participated in a 7-day clinical trial....

  • Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial. Vahedi, K.; Taupin, P.; Djomby, R.; El-Amrani, M.; Lutz, G.; Filipetti, V.; Landais, P.; Massiou, H.; Bousser, M. G. // Journal of Neurology;Feb2002, Vol. 249 Issue 2, p206 

    Backgrounds Familial hemiplegic migraine and episodic ataxia type 2 (EA2) are allelic disorders with distinct types of mutations in the CACNA1A gene. EA2 attacks are remarkably sensitive to acetazolamide, a carbonic anhydrase inhibitor. The effectiveness of acetazolamide in migraine prophylaxis...

  • Pain Freedom at 2 Hours in Migraine after Telcagepant 300 mg. Tfelt-Hansen, Peer // CNS Drugs;2011, Vol. 25 Issue 3, p269 

    The article presents a study on pain freedom at 2 hours in migraine patient after taking 300 milligrams of receptor antagonist telcagepant. It reports on the efficacy of the drug in the randomized controlled trial similar with zolmitriptan 5 milligrams. A chart is presented that shows the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics